Patent · US Active

Antibodies to EGF receptor epitope peptides

US7767792B2 · kind B2 · utility

23Cited by

3References

17Claims

0Family size

Assignees

Inventors

Terrance Grant Johns · Melbourne, AU
Andrew Scott · Melbourne, AU
Antony Wilks Burgess · Melbourne, AU
Lloyd J. Old · New York, US
Timothy Adams · Melbourne, AU
K. Dane Wittrup · Sharon, US
Ginger Chao · Beaumont, US
Peter Anthony Hoyne · Melbourne, AU

Key dates

Filing date	Feb 17, 2005
Grant date	Aug 3, 2010
Priority date	—
Expiry date	Jan 28, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K39/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates generally to growth factor receptor epitope peptides, particularly EGF family receptor epitope peptides. The invention also relates to the use of the receptor peptides in generating antibodies which have anti-tumor or anti-cancer activity or in stimulating an immunological response. The invention further relates to antibodies specifically directed against the receptor peptides. Methods for generating an immune response and for treatment of tumors and cancer are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.